ICYMI! Weekly Market Recap May 21-25, 2018


25-May-2018 21:43 PM



**Reminder The U.S. stock market will be closed on Monday, May 28 for Memorial Day.

Monday the U.S. stock market gap up as US-China trade war is placed "on hold".  Dow Jones up +298.27 points for the day, SPY +0.75%, QQQ +0.56%, IWM +0.66%, IBB -1.32%.

Tuesday the U.S. market drops as POTUS hints the North Korean summit may not happen. Dow closed -178.26 points, IWM -0.72% notable bearish engulfing candle in 12 trading days. IBB +0.32%, QQQ-0.13%.

Wednesday the U.S. market premarket with Dow Jones -200 points, trade war fear is back on. Fed FOMC indicates it will let inflation run above 2% goal for 'temporary period'. See next rate hikes 'soon'. Dow Jones closed +52.40 points, SPY+0.28%, QQQ +0.84%, IWM +0.15%, IBB +0.50%. The U.S. stock market made reversal after the fed minutes.

Thursday President Trump cancels off the North  Korean summit. Dow Jones close -75.67 points. SPY-0.19%, QQQ -0.03%, IWM +0.05%, IBB +0.08%.

Friday Dow Jones closed -58.67 points, SPY -0.24%, QQQ +0.10% and IBB +0.20%


  • Nabriva Therapeutics PLC (NBRV) company announces lefamulin meets all FDA, EMA primary endpoints, but stock trading down
  • NetFlix Inc (NFLX) Former President Obamas enter into a multi-year agreement to produce content for Netflix
  • Celgene Corp (CELG) George Golumbeski departs from management


  • Micron Technology Inc (MU)- announces $10B share repurchase program
  • Adobe Systems Inc (ADBE)-authorizes new $8B stock repurchase program
  • Tesla Inc (TSLA)- share continues two days slide with bad press from Consumer Reports questioned Model 3 brakes


  • Cara Therapeutics Inc (CARA) announced joint venture agreement with Fresenius Medical. Stock up +42.76%
  • Target Corp (TGT) earnings report
  • Esperion Therapeutics Inc (ESPR) Phase 3 study of bempedoic acid meets primary endpoint
  • Netflix, Inc (NFLX) all-time highs at $345.00


  • Recro Pharma (REPH) receives CRL from FDA
  • Celgene Corp (CELG) authorizes $3B common stock repurchase program
  • Dermira (DERM) stock selling off on Investor Day


Thanks for reading. Happy three days weekend.

Contact us: 

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.